GlassScriptPhysician profile
Rohit R Kedia
NPI 1033418249
$3,505.83
in general payments reported to CMS, 2019-2025
34 companies · $642 in 2025
The $642 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $463 · 2021: $440 · 2022: $633 · 2023: $253 · 2024: $180 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718 · Honoraria: $325 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.68 |
| Honoraria | $325.00 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $574.10 | 2019-2024 | Rybelsus, Ozempic |
| Chiesi USA, INC. | $325.00 | 2025 | Mycapssa |
| Dexcom, INC. | $218.80 | 2020-2023 | Dexcom G6 Transmitter |
| Radius Health, INC. | $217.09 | 2019-2023 | |
| Abbott Laboratories | $172.52 | 2022-2025 | Freestyle Libre 3 |
| Medtronic, INC. | $159.04 | 2022-2025 | Minimed 780g |
| Insulet Corporation | $150.17 | 2020-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $147.88 | 2019-2023 | |
| Tandem Diabetes Care, INC. | $134.87 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $130.35 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.87 | 2020-2023 | Synjardy, Jardiance |
| Strongbridge US INC. | $111.00 | 2019 | |
| Pfizer INC. | $98.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.76 | 2021-2025 | |
| Lilly USA, LLC | $86.53 | 2020-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $83.35 | 2019-2022 | |
| Ascensia Diabetes Care US INC. | $82.57 | 2025 | |
| Alexion Pharmaceuticals, INC. | $82.12 | 2022-2025 | Strensiq |
| Amgen INC. | $69.10 | 2019-2020 | |
| Companion Medical, INC. | $59.06 | 2020 | |
| Sobi, INC | $56.10 | 2019-2020 | |
| Clarus Therapeutics INC. | $48.47 | 2021 | |
| Ascendis Pharma Endocrinology INC | $44.95 | 2025 | Yorvipath |
| Medtronic Vascular, INC. | $36.40 | 2019-2020 | |
| Boston Scientific Corporation | $33.22 | 2019 | |
| Medtronic Minimed, INC. | $28.16 | 2020 | |
| Xeris Pharmaceuticals, INC. | $24.93 | 2020 | |
| Daiichi Sankyo INC. | $22.31 | 2022 | |
| Celgene Corporation | $21.16 | 2019 | |
| Glaxosmithkline, LLC. | $21.04 | 2022 | |
| Senseonics, Incorporated | $21.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.04 | 2022 | |
| Horizon Therapeutics Plc | $11.80 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Kedia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.